Alior Bank S.A. (ALR)
Warsaw Stock Exchange · Poland · prices in PLN · close of 23 Oct 2026
Key indicators
| Last close | PLN 128.90 |
|---|---|
| 52-week range | 99.04 – 143.70 |
| Return, 1 month / 3 months | −8.0% / −3.6% |
| Return, 1 year / 3 years | +28.4% / +158.5% |
| Trend | Above 200-day, below 50-day |
| RSI (14) | 41 |
| Volatility (1 year) | 28.8% |
| Worst drawdown (1 year) | -16.0% |
| Average daily value traded | 32.69M PLN |
| Dividend yield | 6.9% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Alior Bank is a commercial bank based in Poland that serves individual customers, small and medium-sized enterprises and larger corporate clients. Its retail offering includes current accounts, savings products, personal loans, mortgages and payment cards, while business customers use its lending, deposit and transaction services. The bank also provides insurance and investment products through its branch network and digital channels, and it operates as a universal bank focused on the Polish market.
Alior Bank S.A. trades under the code ALR on the Warsaw Stock Exchange in Poland, with its price quoted in Polish zloty (PLN). Our dividend records, which start in 2019, show payments in 3 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Alior Bank S.A. (ALR) trades on the Warsaw Stock Exchange in Poland. It last closed at PLN 128.90 on 23 October 2026.
Its price-based Market X-Ray is 76 out of 100 (a strong price profile), ranking 50 of 580 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 28.4% and over the last three months it fell 3.6%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Warsaw Stock Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 75 · Strong | Trading above its long-term averages and near its highs. | |
| Above 200-day average | 4.6% | ||
| From 52-week high | -10.3% | ||
| Momentum | 68 · Fair | Typical recent returns for this exchange. | |
| 3-month return | -3.6% | ||
| 6-month return | 12.4% | ||
| 12-month return, skipping the last month | 39.6% | ||
| Stability (higher is calmer) | 85 · Strong | Calmer than most: low volatility and shallow drawdowns. | |
| Volatility, 1 year (lower is calmer) | 28.8% | ||
| Worst drawdown, 1 year (smaller is calmer) | -16.0% | ||
| Liquidity | 97 · Strong | Trades actively. | |
| Average daily value traded | 32.69M PLN | ||
| Zero-volume days | 0.0% | ||
| Income | 45 · Weak | Dividend is small or irregular. | |
| Dividend yield | 6.9% | ||
| Years with dividends | 3 |
Strengths
- Trend: Trading above its long-term averages and near its highs.
- Stability (higher is calmer): Calmer than most: low volatility and shallow drawdowns.
- Liquidity: Trades actively.
Weak spots
- Income: Dividend is small or irregular.
Returns
| 1 week | −4.0% |
|---|---|
| 1 month | −8.0% |
| 3 months | −3.6% |
| 6 months | +12.4% |
| 1 year | +28.4% |
| 3 years | +158.5% |
| 5 years | +194.1% |
Signals
| 50-day / 200-day average | 133.42 / 123.25 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 3.81 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 12 May 2026 | PLN 8.9300 |
| 27 Jun 2025 | PLN 9.1900 |
| 9 May 2024 | PLN 4.4200 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Warsaw Stock Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.